These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cell, gene and vaccine based strategies in kidney cancer. Gitlitz BJ; Figlin RA Cancer Treat Res; 2003; 116():183-98. PubMed ID: 14650833 [No Abstract] [Full Text] [Related]
25. Status and prospects of gene therapy for urologic cancer. Kumon H Mol Urol; 2000; 4(2):39-40. PubMed ID: 12006238 [No Abstract] [Full Text] [Related]
26. [Algorithms for systemic therapy of prostate cancer, transitional cell carcinoma and renal cell carcinoma]. Eisenhardt A; Ohlmann CH; Doehn C Urologe A; 2020 May; 59(5):533-543. PubMed ID: 32300817 [TBL] [Abstract][Full Text] [Related]
27. [Urologic malignancies in renal transplant candidates and recipients]. Kleinclauss F; Thuret R; Murez T; Timsit MO Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407 [TBL] [Abstract][Full Text] [Related]
29. Status and prospects of gene therapy for urologic cancer. First Meeting of the Japanese Society for Urological Gene Therapy. November 20, 1999. Okayama, Japan. Mol Urol; 2000; 4(2):37-87. PubMed ID: 12362879 [No Abstract] [Full Text] [Related]
30. [Treatment waiting time in urological oncology]. Rouprêt M Prog Urol; 2008 Jul; 18(7):426-7. PubMed ID: 18602601 [No Abstract] [Full Text] [Related]
31. Present status of cancer treatment in Singapore-management of urological cancers. Tun KH; Tan EC; Foo KT Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1139-45. PubMed ID: 1514826 [No Abstract] [Full Text] [Related]
33. [Advances in urologic oncology]. Boccon-Gibod L Prog Urol; 1991 Feb; 1(1):17-21. PubMed ID: 1364643 [No Abstract] [Full Text] [Related]
34. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum. Mongiat-Artus P Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693 [No Abstract] [Full Text] [Related]
35. Potential role for metformin in urologic oncology. Sayyid RK; Fleshner NE Investig Clin Urol; 2016 May; 57(3):157-64. PubMed ID: 27195314 [TBL] [Abstract][Full Text] [Related]
37. [Changing paradigms in the diagnosis (primary and of recurrences) and the treatment of urothelial cancer: preparing the future]. Gelabert Mas A Actas Urol Esp; 2009; 33(7):725-7. PubMed ID: 19757654 [No Abstract] [Full Text] [Related]
38. [Expression of SSX2 gene in human urologic neoplasms]. Du P; Yu LZ; Ma M; Geng L; Wang XS; Xin DQ; Na YQ Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):379-81. PubMed ID: 15854347 [TBL] [Abstract][Full Text] [Related]
39. [Update on the medical treatment of urologic tumors]. Culine S Bull Cancer; 2000 Jan; 87(1):71-5. PubMed ID: 10673634 [No Abstract] [Full Text] [Related]